DNA vaccines and intradermal vaccination by DNA tattooing

Current Topics in Microbiology and Immunology

Volumn 351, Issue 1, 2012, Pages 221-250

  Oosterhuis, K ^a   Van Den Berg, J H ^a   Schumacher, T N ^a   Haanen, J B A G ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DNA VACCINE; DOUBLE STRANDED DNA; NAKED DNA; PEPTIDE VACCINE; TOLL LIKE RECEPTOR 9;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CROSS PRESENTATION; DNA IMMUNIZATION; DNA INTEGRATION; DNA TATTOOING; DRUG ADMINISTRATION ROUTE; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; DRUG SPECIFICITY; DRUG TOLERABILITY; ELECTROPORATION; EX VIVO GENE TRANSFER; GENE DELIVERY SYSTEM; GENE GUN IMMUNIZATION; GENE TARGETING; GENE TRANSFER; HUMAN; IMMUNE RESPONSE; INTRACUTANEOUS VACCINATION; JET INJECTION; MICRONEEDLE ASSISTED GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SIDE EFFECT;

ANIMALS; BACTERIAL INFECTIONS; CLINICAL TRIALS AS TOPIC; DERMIS; DNA; DRUG TOXICITY; ELECTROPORATION; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INJECTIONS, INTRADERMAL; INJECTIONS, JET; LANGERHANS CELLS; MICE; NEEDLES; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; TATTOOING; VACCINATION; VACCINES, DNA; VIRUS DISEASES;

ANIMALIA; PRIMATES;

EID: 80053527464     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82_2010_117     Document Type: Article

References (133)

1. Abdulhaqq SA, Weiner DB (2008) DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 42:219-232
2. Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P (2009) Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 27:7304-7312
3. Babiuk S, Baca-Estrada ME, Foldvari M, Storms M, Rabussay D, Widera G, Babiuk LA (2002) Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 20: 3399-3408 (Pubitemid 35245823)
4. Babiuk S, Mookherjee N, Pontarollo R, Griebel P, van Drunen Littel-van den Hurk S, Hecker R, Babiuk L (2004) TLR9-/-and TLR9+/+ mice display similar immune responses to a DNA vaccine. Immunology 113:114-120 (Pubitemid 39178850)
5. Barouch DH, Letvin NL, Seder RA (2004) The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol Rev 202:266-274 (Pubitemid 39576918)
6. Best SR, Peng S, Juang CM, Hung CF, Hannaman D, Saunders JR, Wu TC, Pai SI (2009) Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine 27:5450-5459
7. Bins AD, Jorritsma A, Wolkers MC, Hung CF, Wu TC, Schumacher TN, Haanen JB (2005) A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 11:899-904 (Pubitemid 41161124)
8. Bins AD, Wolkers MC, van den Boom MD, Haanen JB, Schumacher TN (2007) In vivo antigen stability affects DNA vaccine immunogenicity. J Immunol 179:2126-2133
9. Birchall J, Coulman S, Pearton M, Allender C, Brain K, Anstey A, Gateley C, Wilke N, Morrissey A (2005) Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch micro-fabricated micro-needles. J Drug Target 13:415-421 (Pubitemid 43084542)
10. Bodles-Brakhop AM, Heller R, Draghia-Akli R (2009) Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol Ther 17:585-592
11. Boyle JS, Koniaras C, Lew AM (1997) Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol 9: 1897-1906 (Pubitemid 28005827)
12. Brulet JM, Maudoux F, Thomas S, Thielemans K, Burny A, Leo O, Bex F, Hallez S (2007) DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection. Eur J Immunol 37:376-384 (Pubitemid 46915577)
13. Calarota SA, Weiner DB (2004) Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants. Immunol Rev 199:84-99 (Pubitemid 38736766)
14. Chattergoon MA, Robinson TM, Boyer JD, Weiner DB (1998) Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J Immunol 160:5707-5718 (Pubitemid 28298026)
15. Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM, Wu TC (2000) Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 60: 1035-1042 (Pubitemid 30129542)
16. Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Ling M, Wu TC (2001) Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 108:669-678 (Pubitemid 32906195)
17. Chiarella P, Massi E, De Robertis M, Sibilio A, Parrella P, Fazio VM, Signori E (2008) Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther 8: 1645-1657
18. Cho JH, Youn JW, Sung YC (2001) Cross-priming as a predominant mechanism for inducing CD8 T cell responses in gene gun DNA immunization. J Immunol 167:5549-5557
19. Coban C, Koyama S, Takeshita F, Akira S, Ishii KJ (2008) Molecular and cellular mechanisms of DNA vaccines. Hum Vaccin 4:453-456
20. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD, Jr (1996) DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 2:1122-1128 (Pubitemid 26338632)
21. Dean HJ, Fuller D, Osorio JE (2003) Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis. Comp Immunol Microbiol Infect Dis 26: 373-388 (Pubitemid 37168474)
22. Dean HJ, Haynes J, Schmaljohn C (2005) The role of particle-mediated DNA vaccines in biodefense preparedness. Adv Drug Deliv Rev 57:1315-1342 (Pubitemid 40791114)
23. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA (1997) DNA vaccines. Annu Rev Immunol 15: 617-648 (Pubitemid 27169294)
24. Donnelly J, Berry K, Ulmer JB (2003) Technical and regulatory hurdles for DNA vaccines. Int J Parasitol 33:457-467 (Pubitemid 36638529)
25. Draper SJ, Heeney JL (2010) Viruses as vaccine vectors for infectious diseases and cancer. Nat Rev Microbiol 8:62-73
26. Dupuis M, Denis-Mize K, Woo C, Goldbeck C, Selby MJ, Chen M, Otten GR, Ulmer JB, Donnelly JJ, Ott G, McDonald DM (2000) Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol 165:2850-2858 (Pubitemid 30660737)
27. Frazer IH (2004) Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol 4:46-54 (Pubitemid 38084131)
28. Gao YS, Huang TH, Wang D, Xie QD, Kang XJ (2009) In vivo study on vertical transmission of the HIV-1 gag gene via mouse oocytes. Curr HIV Res 7:562-568
29. Garg S, Oran AE, Hon H, Jacob J (2004) The hybrid cytomegalovirus enhancer/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines. J Immunol 173:550-558 (Pubitemid 38797383)
30. Godin B, Touitou E (2007) Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 59:1152-1161 (Pubitemid 47615204)
31. Gurunathan S, Klinman DM, Seder RA (2000) DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18:927-974 (Pubitemid 30365401)
32. Harden LM, du Plessis I, Poole S, Laburn HP (2006) Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. Physiol Behav 89:146-155
33. Heath WR, Carbone FR (2001) Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19:47-64 (Pubitemid 32368029)
34. Hedley ML, Curley J, Urban R (1998) Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat Med 4:365-368 (Pubitemid 28144100)
35. Hirao LA, Wu L, Khan AS, Satishchandran A, Draghia-Akli R, Weiner DB (2008) Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine 26:440-448
36. Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A (2007) Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology (Oxford) 46:1052-1056 (Pubitemid 47050602)
37. Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, Kawai T, Uematsu S, Takeuchi O, Takeshita F, Coban C, Akira S (2008) TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451:725-729 (Pubitemid 351220566)
38. Ishikawa H, Ma Z, Barber GN (2009) STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:788-792
39. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995 (Pubitemid 41057715)
40. Iwasaki A, Stiernholm BJ, Chan AK, Berinstein NL, Barber BH (1997) Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 158:4591-4601 (Pubitemid 127483777)
41. Iwasaki A, Torres CA, Ohashi PS, Robinson HL, Barber BH (1997) The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 159:11-14
42. Jechlinger W (2006) Optimization and delivery of plasmid DNA for vaccination. Expert Rev Vaccines 5:803-825 (Pubitemid 46021058)
43. Jeon S, Allen-Hoffmann BL, Lambert PF (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69: 2989-2997
44. Johnston SA, Talaat AM, McGuire MJ (2002) Genetic immunization: what's in a name? Arch Med Res 33:325-329 (Pubitemid 35299552)
45. Jones S, Evans K, McElwaine-Johnn H, Sharpe M, Oxford J, Lambkin-Williams R, Mant T, Nolan A, Zambon M, Ellis J, Beadle J, Loudon PT (2009) DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial. Vaccine 27:2506-2512
46. Kim TW, Hung CF, Kim JW, Juang J, Chen PJ, He L, Boyd DA, Wu TC (2004) Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity. Hum Gene Ther 15:167-177 (Pubitemid 38210532)
47. Kim SA, Liang CM, Cheng IC, Cheng YC, Chiao MT, Tseng CJ, Lee F, Jong MH, Tao MH, Yang NS, Liang SM (2006) DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity. J Gene Med 8:1182-1191 (Pubitemid 44480409)
48. Klencke B, Matijevic M, Urban RG, Lathey JL, Hedley ML, Berry M, Thatcher J, Weinberg V, Wilson J, Darragh T, Jay N, Da Costa M, Palefsky JM (2002) Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a phase I study of ZYC101. Clin Cancer Res 8:1028-1037 (Pubitemid 34517636)
49. Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709-760 (Pubitemid 34293438)
50. Kutzler MA, Weiner DB (2008) DNA vaccines: ready for prime time? Nat Rev Genet 9:776-788
51. Kutzler MA, Kraynyak KA, Nagle SJ, Parkinson RM, Zharikova D, Chattergoon M, Maguire H, Muthumani K, Ugen K, Weiner DB (2010) Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo. Gene Ther 17:72-82
52. Laddy DJ, Weiner DB (2006) From plasmids to protection: a review of DNA vaccines against infectious diseases. Int Rev Immunol 25:99-123
53. Ledwith BJ, Manam S, Troilo PJ, Barnum AB, Pauley CJ, Griffiths TG, Harper LB, Beare CM, Bagdon WJ, Nichols WW (2000) Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice. Intervirology 43:258-272 (Pubitemid 32225697)
54. Li M, Davey GM, Sutherland RM, Kurts C, Lew AM, Hirst C, Carbone FR, Heath WR (2001) Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 166:6099-6103 (Pubitemid 32440737)
55. Limbach KJ, Richie TL (2009) Viral vectors in malaria vaccine development. Parasite Immunol 31:501-519
56. Lin CT, Tsai YC, He L, Calizo R, Chou HH, Chang TC, Soong YK, Hung CF, Lai CH (2006) A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity. J Biomed Sci 13:481-488
57. Liu MA (1997) The immunologist's grail: vaccines that generate cellular immunity. Proc Natl Acad Sci USA 94:10496-10498 (Pubitemid 27430761)
58. Liu MA, Ulmer JB (2005) Human clinical trials of plasmid DNA vaccines. Adv Genet 55:25-40 (Pubitemid 43580697)
59. Liu WJ, Gao F, Zhao KN, Zhao W, Fernando GJ, Thomas R, Frazer IH (2002) Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology 301:43-52 (Pubitemid 35168500)
60. Liu L, Zhong Q, Tian T, Dubin K, Athale SK, Kupper TS (2010) Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med 16:224-227
61. Lu S (2008) Immunogenicity of DNA vaccines in humans: it takes two to tango. Hum Vaccin 4:449-452
62. Lu S, Wang S, Grimes-Serrano JM (2008) Current progress of DNA vaccine studies in humans. Expert Rev Vaccines 7:175-191 (Pubitemid 351357954)
63. Luckay A, Sidhu MK, Kjeken R, Megati S, Chong SY, Roopchand V, Garcia-Hand D, Abdullah R, Braun R, Montefiori DC, Rosati M, Felber BK, Pavlakis GN, Mathiesen I, Israel ZR, Eldridge JH, Egan MA (2007) Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 81:5257-5269 (Pubitemid 46744435)
64. Maecker HT, Umetsu DT, DeKruyff RH, Levy S (1998) Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. J Immunol 161:6532-6536 (Pubitemid 28562191)
65. Manam S, Ledwith BJ, Barnum AB, Troilo PJ, Pauley CJ, Harper LB, Griffiths TG, Niu Z, Denisova L, Follmer TT, Pacchione SJ, Wang Z, Beare CM, Bagdon WJ, Nichols WW (2000) Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 43:273-281 (Pubitemid 32225698)
66. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301-305 (Pubitemid 34303674)
67. McCluskie MJ, Brazolot Millan CL, Gramzinski RA, Robinson HL, Santoro JC, Fuller JT, Widera G, Haynes JR, Purcell RH, Davis HL (1999) Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med 5:287-300 (Pubitemid 29342964)
68. McConkey SJ, Reece WH, Moorthy VS, Webster D, Dunachie S, Butcher G, Vuola JM, Blanchard TJ, Gothard P, Watkins K, Hannan CM, Everaere S, Brown K, Kester KE, Cummings J, Williams J, Heppner DG, Pathan A, Flanagan K, Arulanantham N, Roberts MT, Roy M, Smith GL, Schneider J, Peto T, Sinden RE, Gilbert SC, Hill AV (2003) Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med 9:729-735 (Pubitemid 36749222)
69. Michel N, Osen W, Gissmann L, Schumacher TN, Zentgraf H, Muller M (2002) Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Virology 294:47-59 (Pubitemid 34921288)
70. Mir LM (2008) Application of electroporation gene therapy: past, current, and future. Methods Mol Biol 423:3-17
71. Mitragotri S (2005) Immunization without needles. Nat Rev Immunol 5:905-916 (Pubitemid 41746760)
72. Muthumani G, Laddy DJ, Sundaram SG, Fagone P, Shedlock DJ, Kannan S, Wu L, Chung CW, Lankaraman KM, Burns J, Muthumani K, Weiner DB (2009) Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells. Immunology 128:e612-e620
73. Nagata T, Aoshi T, Uchijima M, Suzuki M, Koide Y (2004) Cytotoxic T-lymphocyte-, and helper T-lymphocyte-oriented DNA vaccination. DNA Cell Biol 23:93-106 (Pubitemid 38221926)
74. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ (2009) Skin immune sentinels in health and disease. Nat Rev Immunol 9:679-691
75. Nishikawa M, Huang L (2001) Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12:861-870 (Pubitemid 32681851)
76. Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, Berglund P, Gibbs J, Bennink JR, Yewdell JW (2004) CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304:1318-1321 (Pubitemid 38697427)
77. O'Hagan DT, Rappuoli R (2004) The safety of vaccines. Drug Discov Today 9:846-854 (Pubitemid 39286098)
78. Parker SE, Borellini F, Wenk ML, Hobart P, Hoffman SL, Hedstrom R, Le T, Norman JA (1999) Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits. Hum Gene Ther 10:741-758 (Pubitemid 29168159)
79. Parker SE, Monteith D, Horton H, Hof R, Hernandez P, Vilalta A, Hartikka J, Hobart P, Bentley CE, Chang A, Hedstrom R, Rogers WO, Kumar S, Hoffman SL, Norman JA (2001) Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Ther 8:1011-1023 (Pubitemid 32633378)
80. Peng B, Zhao Y, Xu L, Xu Y (2007) Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity. Vaccine 25:2064-2073 (Pubitemid 46227674)
81. Pokorna D, Rubio I, Muller M (2008) DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants. Genet Vaccines Ther 6:4.
82. Pokorna D, Polakova I, Kindlova M, Duskova M, Ludvikova V, Gabriel P, Kutinova L, Muller M, Smahel M (2009) Vaccination with human papillomavirus type 16-derived peptides using a tattoo device. Vaccine 27:3519-3529
83. Porgador A, Irvine KR, Iwasaki A, Barber BH, Restifo NP, Germain RN (1998) Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med 188:1075-1082 (Pubitemid 28443331)
84. Potthoff A, Schwannecke S, Nabi G, Hoffmann D, Grunwald T, Wildner O, Brockmeyer NH, Uberla K, Tenbusch M (2009) Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccines. Vaccine 27:2768-2774
85. Pulendran B (2004) Immune activation: death, danger and dendritic cells. Curr Biol 14:R30-R32 (Pubitemid 38069967)
86. Pulendran B, Ahmed R (2006) Translating innate immunity into immunological memory: implications for vaccine development. Cell 124:849-863 (Pubitemid 43261457)
87. Quaak SG, van den Berg JH, Toebes M, Schumacher TN, Haanen JB, Beijnen JH, Nuijen B (2008) GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial. Eur J Pharm Biopharm 70:429-438
88. Rabussay D (2008) Applicator and electrode design for in vivo DNA delivery by electroporation. Methods Mol Biol 423:35-59
89. Rao SS, Gomez P, Mascola JR, Dang V, Krivulka GR, Yu F, Lord CI, Shen L, Bailer R, Nabel GJ, Letvin NL (2006) Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model. Vaccine 24:367-373 (Pubitemid 41790440)
90. Redding L, Weiner DB (2009) DNA vaccines in veterinary use. Expert Rev Vaccines 8: 1251-1276
91. Ren S, Li M, Smith JM, DeTolla LJ, Furth PA (2002) Low-volume jet injection for intradermal immunization in rabbits. BMC Biotechnol 2:10
92. Rice J, King CA, Spellerberg MB, Fairweather N, Stevenson FK (1999) Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines. Vaccine 17:3030-3038 (Pubitemid 29366983)
93. Rice J, Ottensmeier CH, Stevenson FK (2008) DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 8:108-120 (Pubitemid 351161331)
94. Robert-Guroff M (2007) Replicating and non-replicating viral vectors for vaccine development. Curr Opin Biotechnol 18:546-556
95. Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P (2006) Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Mol Ther 13:320-327 (Pubitemid 43056897)
96. Roos AK, Eriksson F, Timmons JA, Gerhardt J, Nyman U, Gudmundsdotter L, Brave A, Wahren B, Pisa P (2009) Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One 4:e7226.
97. Saitoh T, Fujita N, Hayashi T, Takahara K, Satoh T, Lee H, Matsunaga K, Kageyama S, Omori H, Noda T, Yamamoto N, Kawai T, Ishii K, Takeuchi O, Yoshimori T, Akira S (2009) Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci USA 106:20842-20846
98. Schalk JA, Mooi FR, Berbers GA, van Aerts LA, Ovelgonne H, Kimman TG (2006) Preclinical and clinical safety studies on DNA vaccines. Hum Vaccin 2:45-53 (Pubitemid 43927157)
99. Scheerlinck JY (2001) Genetic adjuvants for DNA vaccines. Vaccine 19:2647-2656
100. Schneeberger A, Wagner C, Zemann A, Luhrs P, Kutil R, Goos M, Stingl G, Wagner SN (2004) CpG motifs are efficient adjuvants for DNA cancer vaccines. J Invest Dermatol 123:371-379 (Pubitemid 38951833)
101. Schroder K, Muruve DA, Tschopp J (2009) Innate immunity: cytoplasmic DNA sensing by the AIM2 inflammasome. Curr Biol 19:R262-R265
102. Shedlock DJ, Weiner DB (2000) DNA vaccination: antigen presentation and the induction of immunity. J Leukoc Biol 68:793-806
103. Smahel M, Pokorna D, Mackova J, Vlasak J (2004) Enhancement of immunogenicity of HPV16 E7 oncogene by fusion with E. coli beta-glucuronidase. J Gene Med 6:1092-1101 (Pubitemid 40232987)
104. Smith HA, Klinman DM (2001) The regulation of DNA vaccines. Curr Opin Biotechnol 12: 299-303 (Pubitemid 32524343)
105. Spies B, Hochrein H, Vabulas M, Huster K, Busch DH, Schmitz F, Heit A, Wagner H (2003) Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J Immunol 171:5908-5912 (Pubitemid 37467208)
106. Stevenson FK, Rice J, Ottensmeier CH, Thirdborough SM, Zhu D (2004) DNA fusion gene vaccines against cancer: from the laboratory to the clinic. Immunol Rev 199:156-180 (Pubitemid 38736770)
107. Sun J, Li D, Hao Y, Zhang Y, Fan W, Fu J, Hu Y, Liu Y, Shao Y (2009) Posttranscriptional regulatory elements enhance antigen expression and DNA vaccine efficacy. DNA Cell Biol 28:233-240
108. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501-505 (Pubitemid 47123520)
109. Tang CK, Pietersz GA (2009) Intracellular detection and immune signaling pathways of DNA vaccines. Expert Rev Vaccines 8:1161-1170
110. Tang DC, DeVit M, Johnston SA (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356:152-154
111. Thomsen LL, Topley P, Daly MG, Brett SJ, Tite JP (2004) Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery. Vaccine 22:1799-1809 (Pubitemid 38447228)
112. Torres CA, Iwasaki A, Barber BH, Robinson HL (1997) Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol 158:4529-4532 (Pubitemid 127483769)
113. Trimble C, Lin CT, Hung CF, Pai S, Juang J, He L, Gillison M, Pardoll D, Wu L, Wu TC (2003) Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 21:4036-4042 (Pubitemid 37345135)
114. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A et al (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749 (Pubitemid 23114660)
115. Ulmer JB, Deck RR, DeWitt CM, Donnhly JI, Liu MA (1996) Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89:59-67 (Pubitemid 26284039)
116. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y (2009) Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27:454-459
117. Van Den Berg JH, Nujien B, Beijnen JH, Vincent A, van Tinteren H, Kluge J, Woerdeman LA, Hennink WE, Storm G, Schumacher TN, Haanen JB (2009) Optimization of intradermal vaccination by DNA tattooing in human skin. Hum Gene Ther 20:181-189
118. Van Den Berg JH, Oosterhuis K, Hennink WE, Storm G, van der Aa LJ, Engbersen JF, Haanen JB, Beijnen JH, Schumacher TN, Nuijen B (2010a) Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. J Control Release 141:234-240
119. Van Den Berg JH, Nuijen B, Schumacher TN, Haanen JB, Storm G, Beijnen JH, Hennink WE (2010b) Synthetic vehicles for DNA vaccination. J Drug Target 18:1-14
120. Van Den Berg JH, Quaak SG, Beijnen JH, Hennink WE, Storm G, Schumacher TN, Haanen JB, Nuijen B (2010c) Lipopolysaccharide contamination in intradermal DNA vaccination: Toxic impurity or adjuvant? Int J Pharm 390:32-36
121. Van Oijen M, Bins A, Elias S, Sein J, Weder P, de Gast G, Mallo H, Gallee M, van Tinteren H, Schumacher T, Haanen J (2004) On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients. Clin Cancer Res 10:4754-4760 (Pubitemid 38955527)
122. Verstrepen BE, Bins AD, Rollier CS, Mooij P, Koopman G, Sheppard NC, Sattentau Q, Wagner R, Wolf H, Schumacher TN, Heeney JL, Haanen JB (2008) Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates. Vaccine 26:3346-3351
123. Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB (1993) Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90:4156-4160 (Pubitemid 23134185)
124. Wang Z, Troilo PJ, Wang X, Griffiths TG, Pacchione SJ, Barnum AB, Harper LB, Pauley CJ, Niu Z, Denisova L, Follmer TT, Rizzuto G, Ciliberto G, Fattori E, Monica NL, Manam S, Ledwith BJ (2004) Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Ther 11:711-721 (Pubitemid 38519279)
125. Widera G, Austin M, Rabussay D, Goldbeck C, Barnett SW, Chen M, Leung L, Otten GR, Thudium K, Selby MJ, Ulmer JB (2000) Increased DNA vaccine delivery and immunoge-nicity by electroporation in vivo. J Immunol 164:4635-4640 (Pubitemid 30238062)
126. Wilson CB, Marcuse EK (2001) Vaccine safety-vaccine benefits: science and the public's perception. Nat Rev Immunol 1:160-165 (Pubitemid 33741970)
127. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468
128. Wolkers MC, Toebes M, Okabe M, Haanen JB, Schumacher TN (2002) Optimizing the efficacy of epitope-directed DNA vaccination. J Immunol 168:4998-5004 (Pubitemid 34495962)
129. Wolkers MC, Brouwenstijn N, Bakker AH, Toebes M, Schumacher TN (2004) Antigen bias in T cell cross-priming. Science 304:1314-1317 (Pubitemid 38697426)
130. Wu TC (2007) Therapeutic human papillomavirus DNA vaccination strategies to control cervical cancer. Eur J Immunol 37:310-314
131. Yamano T, Kaneda Y, Huang S, Hiramatsu SH, Hoon DS (2006) Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant. Mol Ther 13:194-202 (Pubitemid 41763498)
132. Zaba LC, Krueger JG, Lowes MA (2009) Resident and " inflammatory" dendritic cells in human skin. J Invest Dermatol 129:302-308
133. Zhou Q, Wang F, Yang F, Wang Y, Zhang X, Sun S (2010) Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant. Vaccine 28:1357-1362